Los conductores jóvenes ya no sólo se distraen con las pantallas táctiles de los coches: “están grabando TikToks”April 18, 2026
Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to TumorsNews DeskApril 15, 20260 Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
Two New Takes on Making a Type of Targeted Cancer Therapy Even BetterNews DeskApril 12, 20260 Antibody drug conjugates bring a targeted approach to the treatment of many types of cancer, but there’s still room for…
16 of the most interesting startups from YC W’26 Demo DayNews DeskMarch 26, 20260 AI was once again the buzzword for this latest batch of YC Demo Day companies. Nearly 190 companies participated in…
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork News DeskMarch 25, 20260 The promise of modern healthcare has always centered on people: patients seeking care, clinicians delivering it, and other team members working to keep…
Gilead Sciences Gains an Opportunity for Immune System Reset With $1.7B Ouro AcquisitionNews DeskMarch 24, 20260 Gilead Sciences identified inflammation as an area for pipeline and revenue growth and the company is expanding its prospects through…
Why Novartis Is Paying $2B for a Cancer Drug That Hits the Same Target as One of Its Own ProductsNews DeskMarch 23, 20260 Breast cancers driven by a particular genetic signature can already be treated by a particular class of targeted therapies, but…
Vibe-coding startup Lovable is on the hunt for acquisitionsNews DeskMarch 23, 20260 Lovable, the AI-powered app-building platform last valued at $6.6 billion, is on the hunt for acquisitions. On Monday, the startup’s…